等待开盘 09-16 09:30:00 美东时间
-0.530
-5.98%
Prothena Corp (NASDAQ:PRTA) reported quarterly losses of $(0.36) per share which missed the analyst consensus estimate of $(0.09) by 300 percent. This is a 79.19 percent increase over losses of $(1.73) per share from the same period last year. The company reported quarterly sales of $1.010 million w...
08-07 15:42
阿尔茨海默病相关个股在常规交易时段走高。 相关个股涨幅数据:礼来上涨6.2%,渤健涨幅达6.1%,Prothena攀升3.5%。 译文内容由第三方软件翻译。 声...
06-26 22:06
https://www.sec.gov/Archives/edgar/data/1559053/000104546326000004/xslF345X06/primary_doc.xml
05-27 03:00
今日重点评级关注:HC Wainwright & Co.:维持Artiva Biotherapeutics"买入"评级,目标价从15美元升至35美元;韦德布什:维持Cullinan Therapeutics"跑赢大市"评级,目标价从36美元升至37美元
05-11 15:43
Citizens analyst Jason N. Butler maintains Prothena Corp (NASDAQ:PRTA) with a Market Outperform and raises the price target from $19 to $20.
05-08 23:15
Prothena Corporation plc (NASDAQ:PRTA) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to coramitug, a potential best-in-class amyloid depleter antibody currently in
04-28 04:12
新浪财经ESG评级中心提供包括资讯、报告、培训、咨询等在内的14项ESG服务,助力上市公司传播ESG理念,提升ESG可持续发展表现。点击查看【 ESG评级中...
03-24 10:28
Prothena ( ($PRTA) ) has shared an announcement. On February 27, 2026, Prothena...
02-28 06:42
Prothena shares are trading higher after the company announced a $100 million s...
02-28 05:17